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Abstract
Introduction: Diabetic myonecrosis was first reported by Angervall and Stener in 1965. In its
classical clinical expression, it affects type 1 diabetes mellitus patients with long-standing poor
metabolic control and advanced chronic microvascular complications. A sudden-onset of severe
pain in the region of the involved muscle, usually the quadriceps, is the typical clinical manifestation.
Magnetic resonance imaging (MRI) confirms the clinical diagnosis; in some cases of diagnostic
uncertainty, a muscle biopsy may be required.
Case Presentation: We present the case of a 38 year-old Hispanic male from Mexico, with
alcohol-induced hepatic cirrhosis (Child-Pugh C/MELD 45) and type 2 diabetes mellitus admitted
to the emergency room due to hepatic encephalopathy with intense pain and an increase in volume
of the left thigh. MRI showed edema and inflammatory changes of the quadriceps muscle with a
hyperintense signal on T2-weighted images; in addition, there was a subacute hematoma.
Conclusion: To the best of our knowledge, this is the first case of diabetic myonecrosis associated
with and complicated by advanced hepatic cirrhosis reported in the literature.
Introduction
Diabetic myonecrosis was first reported by Angervall and
Stener in 1965 [1]. In its classical clinical expression, it
affects people with type 1 diabetes mellitus with long-
standing poor metabolic control and advanced chronic
microvascular complications. The typical clinical manifes-
tation is the sudden onset of severe pain in the region of
the involved muscle, usually the quadriceps. Magnetic res-
onance imaging (MRI) confirms the clinical diagnosis. In
some cases of diagnostic uncertainty, a muscle biopsy may
be required. Management of diabetic myonecrosis
involves bed rest, adequate pain control and improve-
ment of diabetes metabolic control. It has a poor progno-
sis and is a reflection of severe and generalized
vasculopathy that can produce critical and fatal complica-
tions in the short-term [2].
Case presentation
A 38-year-old Hispanic male from Mexico, with alcohol-
induced hepatic cirrhosis (Child-Pugh C/MELD 45) and
type 2 diabetes mellitus was admitted to the emergency
room due to deteriorating encephalopathy. His diabetes
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during this time was very poor because of alchoholism.
One month before being admitted to the emergency
room, he experienced sudden onset of increasing local-
ized pain in the left thigh while resting. He had no fever
or chills. Relatives said he did not experience trauma, skin
lesions and insect bites. Analgesics only mildly soothed
the pain. In the following weeks, he was unable to walk.
Common oral analgesics no longer delivered relief from
moderate to severe pain. He remained at rest until three
days before admission when the encephalopathy wors-
ened. During physical examination, he had no fever. His
blood pressure was at 110/70 mmHg, his pulse rate was at
112. His respiratory rate was 24 per minute. He was con-
scious and oriented with grade II encephalopathy. Upon
examining the left thigh, a 10 × 10 cm mass was located in
the anterior and external part of the middle portion of the
thigh. This lesion was not well-defined. It was tender and
associated with tense skin with erythema, ecchymoses and
an increase in temperature. He The patient experienced
increased pain in the thigh when moving the limb. There
was no peripheral edema. Ollow's sign and Homman's
sign were absent. On neurological examination, vibratory
and pain perception were bilaterally decreased.
Blood testing (see table 1) showed a macrocytic, normo-
chromic anemia with neutrophilic leucocytosis, thrombo-
cytopenia and prolongation of coagulation times. A non-
fasting plasma glucose value was elevated. Blood cultures
and antiphospholipid antibodies were negative. X-ray
imaging of the left thigh showed only soft tissue edema; a
Doppler ultrasound ruled out deep vein thrombosis and
an MRI showed edema and inflammatory changes of the
quadriceps muscle with a hyperintense signal on T2-
weighted images. There was also a subacute hematoma
(Figure 1).
Once diabetic myonecrosis and subacute hematoma were
diagnosed, conservative management was initiated. Treat-
ment included complete bed rest, parenteral analgesics
and antibiotics to prevent spontaneous bacterial peritoni-
tis. Therapy for hepatic encephalopathy, decompensated
liver cirrhosis, and diabetes was also provided. There was
a rapid improvement in pain control and resolution of the
edema and the area of cellulitis. Five days later, however,
there was increased pain in the erythematous area of the
thigh. He also experienced low grade fever. An ultrasound
guided muscle biopsy revealed only necrosis. Gram stain
and cultures for anaerobic and aerobic bacteria and fungi
were negative. During the procedure, partial evacuation of
the subacute hematoma was carried out. After a slow and
progressive improvement of the mass and edema, he was
discharged from the hospital. Three weeks later, he came
back to the emergency room with grade IV encephalopa-
thy. Examination of the limbs did not reveal any abnor-
malities. Progressive deterioration of hepatic function led
to severe liver insufficiency and death four days after
admission.
Discussion
Myonecrosis related to diabetes mellitus is an uncommon
disorder. To date, only about 100 cases have been pub-
Table 1: Laboratory values on admission and some evolution landmarks
Value on admission week 1 week 2 reference value
Hematocrit (%) 22.8 18 25 37.7-53.7
Hemoglobin (g/dl) 7.9 6.36 8.79 12.2-18.1
Mean corpuscular volume (μm3) 101 104 98.4 80-97
Leucocytes (k/mm3) 17 9.290 7.270 4 - 11
Differential count (mm3)
Neutrophils (k/mm3) 13.300 6.690 5.160 2.0-6.9
Lymphocytes (k/mm3) 1.440 1.030 0.977 0.6-3.4
Platelets (mm3) 46,000 41,100 11,400 140,000 - 425,000
Prothrombin time (s) 40.9 25 47 10.7-14.3
Partial thromboplastin time (s) 100 43 47 22.0-38.0
INR 5.4 3 4.8
Erythrocyte Sedimentation rate (mm/hr) 16 < 10
Glucose (mg/dl) 145 85 102 70-100
Creatinine (mg/dl) 2.8 3.04 2 0.6-1.4
Proteins (gr/dl) 7.2 7 6.1-7.9
Albumin (g/dl) 1.8 1.7 3.5-4.8
Globulin (g/dl) 5.4 5.2 2.6-3.1
Aspartate aminotranspherase (U/Liter) 121 94 10.0-42
Alanine aminotranspherase (U/Liter) 72 63 10.0-42
Total bilirrubin (mg/dl) 11.14 11.8 0.2-1.0
Direct (mg/dl) 5 4.9 0.0-0.2
Alkaline Phosphatase (U/liter) 108 108 38-126
Creatine phosphokinase (U/liter) 138 22-262Page 2 of 5
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posed as the underlying mechanism that leads to
spontaneous, non-gangrenous and focalized muscle inf-
arction. There has also been some evidence that abnor-
malities in fibrinolysis and coagulation, embolic
phenomenon and vasculitis can contribute in a minority
of cases. This case is notable because of the association of
diabetic myonecrosis with liver cirrhosis. This is the first
reported case where both disorders were associated. Pro-
longed clotting time secondary to severe chronic liver
damage almost surely contributed to formation of the
hematoma, a complication that has not been previously
observed in a patient with diabetic myonecrosis. This
complication made the risk of infection likely. Evacuation
of the hematoma in the presence of low grade fever during
hospitalization was performed based on a high risk of
infection. Despite improvement of this problem and the
encephalopathy, it is possible that some kind of occult or
asymptomatic infection contributed to the rapid deterio-
ration of hepatic function, leading to irreversible and fatal
hepatic insufficiency. Diabetic myonecrosis is a little
known complication of diabetes, which is associated with
a poor prognosis, requiring a high degree of suspicion.
Diabetic myonecrosis is a sporadic microvascular compli-
cation favored by poor metabolic control. It is related to
other complications of diabetes mellitus, such as neph-
ropathy (71%), retinopathy (56%) and neuropathy
(54%) [1-3]. Long-term diabetic vasculopathy is essential
for developing diabetic myonecrosis [4]. Classically, it has
been reported in women with long-standing diabetes (15
years from diagnosis); type 1 diabetes is present in most
cases (71%) [1,2,5]. In type 2 diabetes cases, it character-
istically affects elderly patients.
Although not well defined, atheroembolism of small ves-
sels has also been proposed as the responsible mecha-
nism. It is likely that preference for the thigh muscles is
due to the presence of multiple collateral vessels. Another
proposed theory is the participation of the coagulation
Magnetic resonance imaging of the left thighFigure 1
Magnetic resonance imaging of the left thigh. A) Coronal slice on T-2 sequence: hyperintense image of the quadriceps 
muscle in relation to inflammatory changes and necrosis (arrows). B) Axial slice on T-2 sequence: hyperintense image of the 
quadriceps muscle (white arrow), there is a fluid collection lateral to the vascular bundle (black arrow).Page 3 of 5
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tem [2,6].
Sudden onset of intense pain of the involved muscle of
the patient is the usual initial manifestation. There is clear
predilection for the thigh muscles; the disease rarely
involves the muscles bilaterally. In most cases, a diffuse,
rapidly progressive pain radiates to the low back, the knee
and foot, making daily activities impossible. Fever has
been reported in only 3% of subjects [1-7]. An increase in
volume of the thigh is the first clinical sign. At the begin-
ning it is not well delineated, but later it is localized to the
implicated muscle. It may be associated with joint effu-
sion. A palpable mass occurs in 40% of patients at presen-
tation. Nerve compression is rare and motility restriction
of the limb is a result of intense pain [5,7]. The quadriceps
cruralis is the most commonly involved muscle (87%) and
the vastus lateralis and vastus medialis are implicated in
24% and 22%, respectively. The abductors, hip flexors
and muscles of the upper limb are rarely affected. Bilateral
disease has been reported in about 10% of cases [6].
Lab testing is unhelpful. Creatine phosphokinase levels
are normal or slightly elevated in 52%; leukocytosis
occurs in 14% of cases. AST, ALT, LDH levels and the
erythrocyte sedimentation rate are normal most times
[8,5]. Deep vein thrombosis is the main differential diag-
nosis. Second place is occupied by entities that need to be
ruled out, such as hematomas, pseudothrombophlebitis,
acute arterial occlusion, abscesses, cellulitis, fascitis, bursi-
tis and diabetic pyomyositis. It is sometimes difficult to
distinguish diabetic myonecrosis from lumbosacral radic-
uloplexopathy, diabetic osteomielitis, muscle rupture,
tumors, polymyositis or proliferative myositis.
A high degree of suspicion is required. With physical
examination, it is difficult to identify the disease. Studies
such as x-ray imaging, Doppler ultrasound, contrasted CT
scan, angiography and MRI usually rules out other etiolo-
gies. MRI usually defines the diagnosis of diabetic
myonecrosis. Magnetic resonance imaging shows a hyper-
intense signal in the T2 sequence of the involved muscle.
Perimuscular or subcutaneous tissue edema are common.
A hyperintense signal in the T1 sequence is sometimes
observed, probably due to hemorrhage secondary to
necrosis [9,10]. In very rare cases, a biopsy is required to
confirm the diagnosis, mostly because of a lack of
response to standard therapy [8,6,10].
Biopsy is the gold standard for diagnosis. But before
undergoing it, there must be a clear indication, due to the
risk of complications. A fine-needle percutaneous biopsy
is preferred to open biopsy because of the risk of infection
or hematoma [10,3]. Review of the biopsy shows areas of
hemorrhagic necrosis and myositis with muscle fibers in
different stages of degeneration-regeneration. The walls of
small vessels are hyalinized with partial or total occlusion
of the vessel lumen. In medium-sized vessels, atheroscle-
rosis is observed [4,2,6,3]. Cultures for bacteria, fungi and
acid-fast bacilli should be performed, but are negative
unless complicated myonecrosis has taken place.
Control of pain and inflammation are the mainstay of
therapy. Absolute bed rest and the use of non-steroidal
anti-inflammatory drugs or narcotics can have a slow but
progressive improvement. The use of concurrent anti-
platelet and anti-inflammatory drugs may accelerate total
recovery time from eight to five weeks [4,3]. Better meta-
bolic control of the diabetic state is recommended;
although there is no evidence that this will prevent mor-
bidity or mortality. A hypercoagulable state should be
considered and anticoagulation started if confirmed [6,3].
Surgical treatment is recommended for decompression in
case of arterial compromise [8].
Most of the time, the short-term prognosis is excellent.
Less than eight weeks are needed for pain and inflamma-
tion to disappear. The main underlying difficulty is
advanced generalized microvasculopathy leading to life-
threatening complications in a short period [2,11]. Up to
50% of cases may have a recurrence, most of them in a
previously affected muscle [2,6]. Almost half of these
recurrent events occur in a period of two months [12].
Conclusion
This is the first case of diabetic myonecrosis associated
with and complicated by advanced hepatic cirrhosis
reported in the literature.
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